Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19

(2020) M.L. Solodky et al.   ANNALS OF ONCOLOGY

Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

(2020) Jiuxin Qu et al.   CLINICAL INFECTIOUS DISEASES

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

(2020) Li Guo et al.   CLINICAL INFECTIOUS DISEASES

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

(2020) Juanjuan Zhao et al.   CLINICAL INFECTIOUS DISEASES

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Profile of specific antibodies to SARS-CoV-2: The first report

(2020) Ai Tang Xiao et al.   JOURNAL OF INFECTION

Detection of antibodies against SARS-CoV-2 in patients with COVID-19

(2020) Zhe Du et al.   JOURNAL OF MEDICAL VIROLOGY

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection

(2020) Qingqing Lin et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience

(2020) Anthony R. Mato et al.   BLOOD

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Perturbation of the normal immune system in patients with CLL

(2015) F. Forconi et al.   BLOOD